# Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome

> **NCT01994941** · PHASE4 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 133 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT01994941
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994941, "Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01994941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*